PRF Technologies Ltd. (PRFX) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

PRF Technologies Ltd. (PRFX) closed at USD 0.82 on 2026-10-14, a change of -87.5 % over the past year, with a market capitalization of USD 2.96M.

PRF Technologies Ltd. recent closing prices

DateClose (USD)
2026-10-140.82
2026-10-130.82
2026-10-120.86
2026-10-090.88
2026-10-080.86
2026-10-070.88
2026-10-060.88

The most recent trading day is not shown. For full charts and indicators use the analysis page.

PRF Technologies Ltd. key figures

Previous close
USD 0.82 (2026-10-14)
1-year change
-87.5 %
Market cap
USD 2.96M
Enterprise value
USD -8.31M
P/E ratio (trailing)
-0.20
P/E ratio (forward)
-0.07
EPS (trailing)
-4.23
EPS (forward)
-12.06
PEG ratio
n/a
Price to book
0.16
Revenue growth
n/a
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
0.07
Employees
6
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About PRF Technologies Ltd.

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for PRF Technologies Ltd. and compare it with other stocks.

Analyze PRFXAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell PRF Technologies Ltd. shares.